Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Ocular Therapeutix (OCUL): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
17 analysts
Options Flow (P/C)
—
Avg Consensus PT
$22
+218.4%
Highest Price Target
$31
+344.8%
Lowest Price Target
$14
+100.9%
Short Interest
15.8%
Declining — Bullish
Insider Activity (30d)
Net Seller
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 12, 2026 | UBS | Alice Nettleton— | +100.9% | $14 | Initiate | Buy |
| Oct 2, 2026 | Chardan Capital | Andreas Argyrides— | +230.0% | $23 → $23 | Maintained | Buy |